Pipeline

Place: Japan

Development No.
Generic name
Therapeutic Category Dosage form Stage
T-4288 Fluoroketolide antibiotic
(Otorhinolaryngology infectious disease)
Oral NDA filing
T-4288 Fluoroketolide antibiotic
(Respiratory infectious disease)
Oral Phase 3
Favipiravir Anti-SFTS (serious fever with thrombocytopenia syndrome) virus agent Oral

Approval
(June 2024)

(As of Aug. 2024)

FUJIFILM Toyama Chemical Co., Ltd. has following patent rights.
Acts of making, selling or offering to sell these compounds infringe the following patent rights of FUJIFILM Toyama Chemical Co., Ltd. without the permission of FUJIFILM Toyama Chemical Co., Ltd.
Please make sure not to infringe the patent rights of FUJIFILM Toyama Chemical Co., Ltd.

Favipiravir

Japanese patent No. 3453362